clorgyline has been researched along with Cardiac Remodeling, Ventricular in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaludercic, N | 1 |
| Takimoto, E | 1 |
| Nagayama, T | 1 |
| Feng, N | 1 |
| Lai, EW | 1 |
| Bedja, D | 1 |
| Chen, K | 1 |
| Gabrielson, KL | 1 |
| Blakely, RD | 1 |
| Shih, JC | 1 |
| Pacak, K | 1 |
| Kass, DA | 1 |
| Di Lisa, F | 1 |
| Paolocci, N | 1 |
1 other study available for clorgyline and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.
Topics: Animals; Blood Pressure; Cardiomegaly; Clorgyline; Heart Failure; Heart Ventricles; Hydrogen Peroxid | 2010 |